ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for monitor 브라질 증권 거래소, NASDAQ, NYSE, AMEX, LSE 등 주요 거래소에서의 다양한 실시간 주식 시세를 모니터링합니다.
SIGA Technologies Inc

SIGA Technologies Inc (SIGA)

6.45
-0.02
(-0.31%)
마감 27 1월 6:00AM
6.45
0.005
(0.08%)
시간외 거래: 8:56AM

포트폴리오 강화: 실시간 토론 및 실행 가능한 거래 아이디어.

주요 통계 및 세부정보

가격
6.45
매수가
6.45
매도가
6.57
거래량
263,815
6.395 일간 변동폭 6.61
4.26 52주 범위 12.83
market_cap
전일 종가
6.47
개장가
6.49
최근 거래 시간
20
@
6.45
마지막 거래 시간
재정 규모
US$ 1,702,443
VWAP
6.4532
평균 볼륨(3m)
488,696
발행 주식
71,404,669
배당수익률
-
주가수익률
6.76
주당순이익(EPS)
0.95
매출
139.92M
순이익
68.07M

SIGA Technologies Inc 정보

SIGA Technologies Inc is a commercial-stage pharmaceutical company focused on the health security market. The company's lead product is TPOXX, an orally administered antiviral drug for the treatment of human smallpox disease caused by the variola virus. Its products target orthopoxvirus infections i... SIGA Technologies Inc is a commercial-stage pharmaceutical company focused on the health security market. The company's lead product is TPOXX, an orally administered antiviral drug for the treatment of human smallpox disease caused by the variola virus. Its products target orthopoxvirus infections including smallpox. 더 보기

섹터
Pharmaceutical Preparations
산업
Pharmaceutical Diversified
웹사이트
본부
Wilmington, Delaware, USA
설립됨
1995
SIGA Technologies Inc is listed in the Pharmaceutical Preparations sector of the 나스닥 with ticker SIGA. The last closing price for SIGA Technologies was US$6.47. Over the last year, SIGA Technologies shares have traded in a share price range of US$ 4.26 to US$ 12.83.

SIGA Technologies currently has 71,404,669 shares in issue. The market capitalisation of SIGA Technologies is US$461.99 million. SIGA Technologies has a price to earnings ratio (PE ratio) of 6.76.

SIGA 최신 뉴스

TEPOXX (tecovirimat) Approved in Japan for the Treatment of Orthopoxviruses

Regulatory decision marks first approval in Japan of an antiviral for the treatment of orthopoxviruses including smallpox, mpox and cowpoxJapan Biotechno Pharma Co., Ltd. engaged as exclusive...

Interim Results from STOMP Study of SIGA’s Tecovirimat in Treatment of Mpox Announced

Interim analysis shows that tecovirimat did not improve time to lesion resolution compared to placebo in adults with mild to moderate clade II mpoxStudy stopped enrolling patients in all study...

SIGA Reports Financial Results for Three and Nine Months Ended September 30, 2024

Product Revenues for the Three and Nine months Ended September 30, 2024 were $9 million and $53 million, respectivelyReceived $122 Million of Procurement Orders from the U.S. Government in the...

SIGA to Host Business Update Call on November 7 Following Release of Third-Quarter 2024 Financial Results

NEW YORK, Oct. 31, 2024 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (NASDAQ: SIGA), a commercial-stage pharmaceutical company, today announced that management will host a webcast and...

기간변동변동 %시가고가저가평균 일일 거래량VWAP
10.15632.483435816776.29376.456.1653008406.31529827CS
40.457.566.585.753782036.22699037CS
12-0.85-11.64383561647.37.975.6154886966.56883328CS
26-3.18-33.02180685369.6312.835.6159549938.77070246CS
521.3426.22309197655.1112.834.268468208.33252742CS
1560.243.864734299526.2126.994.215221894212.69349578CS
2601.2423.80038387725.2126.993.96143443212.2279809CS

SIGA - Frequently Asked Questions (FAQ)

What is the current SIGA Technologies share price?
The current share price of SIGA Technologies is US$ 6.45
How many SIGA Technologies shares are in issue?
SIGA Technologies has 71,404,669 shares in issue
What is the market cap of SIGA Technologies?
The market capitalisation of SIGA Technologies is USD 461.99M
What is the 1 year trading range for SIGA Technologies share price?
SIGA Technologies has traded in the range of US$ 4.26 to US$ 12.83 during the past year
What is the PE ratio of SIGA Technologies?
The price to earnings ratio of SIGA Technologies is 6.76
What is the cash to sales ratio of SIGA Technologies?
The cash to sales ratio of SIGA Technologies is 3.29
What is the reporting currency for SIGA Technologies?
SIGA Technologies reports financial results in USD
What is the latest annual turnover for SIGA Technologies?
The latest annual turnover of SIGA Technologies is USD 139.92M
What is the latest annual profit for SIGA Technologies?
The latest annual profit of SIGA Technologies is USD 68.07M
What is the registered address of SIGA Technologies?
The registered address for SIGA Technologies is 251 LITTLE FALLS DRIVE, WILMINGTON, DELAWARE, 19808
What is the SIGA Technologies website address?
The website address for SIGA Technologies is www.siga.com
Which industry sector does SIGA Technologies operate in?
SIGA Technologies operates in the PHARMACEUTICAL DIVERSIFIED sector

이동자

모두 보기
  • 가장 활성
  • % 상승자
  • % 패자
기호가격볼륨
NVNINVNI Group Ltd
US$ 4.38
(193.96%)
366.98M
EVAXEvaxion Biotech AS
US$ 5.99
(64.56%)
55.41M
ELABPMGC Holdings Inc
US$ 3.0901
(56.07%)
76.48M
PCLAPicoCELA Inc
US$ 4.60
(49.35%)
3.75M
GOEVCanoo Inc
US$ 0.475
(43.94%)
282.22M
GODNUGolden Star Acquisition Corporation
US$ 3.11
(-75.82%)
17.51k
GODNGolden Star Acquisition Corporation
US$ 2.93
(-65.67%)
902.76k
NXTTNext Technology Holding Inc
US$ 1.37
(-54.93%)
2.56M
SGLYSingularity Future Technology Ltd
US$ 1.625
(-38.45%)
917.77k
WHLRLWheeler Real Estate Investment Trust Inc
US$ 90.11
(-38.07%)
8
ACONAclarion Inc
US$ 0.0557
(28.94%)
811.91M
NVNINVNI Group Ltd
US$ 4.38
(193.96%)
366.98M
RIMEAlgorhythm Holdings Inc
US$ 0.0357
(4.69%)
284.97M
GOEVCanoo Inc
US$ 0.475
(43.94%)
282.22M
NVDANVIDIA Corporation
US$ 142.62
(-3.12%)
232.88M

SIGA Discussion

게시물 보기
81vette 81vette 5 월 전
Charting up today,might be a good holiday swing
👍️0
TheFinalCD TheFinalCD 5 월 전
SIGA Announces New Contract Awarded by U.S. Department of Defense for the Procurement of $9 Million of TPOXX®

https://investor.siga.com/investors/news/news-details/2024/SIGA-Announces-New-Contract-Awarded-by-U.S.-Department-of-Defense-for-the-Procurement-of-9-Million-of-TPOXX/default.aspx

https://www.cdc.gov/poxvirus/mpox/clinicians/tecovirimat-ea-ind.html
👍️0
Biggiee Biggiee 5 월 전
Hell of a bounce back! $6-$9 but will it hold?
👍️0
Biggiee Biggiee 5 월 전
Drug fail, oopsie!
👍️0
Biggiee Biggiee 5 월 전
Boom town, monkey biz
👍️0
Monksdream Monksdream 9 월 전
SIGA under $10

👍️0
Monksdream Monksdream 10 월 전
SIGA under $10
👍️0
Capitalvaluetrade Capitalvaluetrade 1 년 전
SIGA 75k share buy at close almost half a million $, very nice
👍️0
pennypauly pennypauly 1 년 전
Break 6.59 and we should touch 8
👍️0
pennypauly pennypauly 1 년 전
Bottom in, 5.32
👍️0
Capitalvaluetrade Capitalvaluetrade 1 년 전
SIGA 1-Yr Chart and Recent News Looking Good
👍️0
Monksdream Monksdream 2 년 전
SIGA look at the insider selling
👍️0
TheFinalCD TheFinalCD 2 년 전
SIGA 6.36 pullin back
👍️0
TheFinalCD TheFinalCD 2 년 전
nice find...

SIGA Announces U.S. Government Procurement Orders of Approximately $138 Million for Oral and IV TPOXX®
https://finance.yahoo.com/news/siga-announces-u-government-procurement-204500111.html

https://finviz.com/quote.ashx?t=SIGA&p=d
👍️0
Monksdream Monksdream 2 년 전
SIGA
👍️0
subslover subslover 2 년 전
Certainly is a beautiful contract.
👍️0
pennypauly pennypauly 2 년 전
Nice picked up some AH
👍️ 1
subslover subslover 2 년 전
SIGA Announces U.S. Government Procurement Orders of Approximately $138 Million for Oral and IV TPOXX®
Exercise of Procurement Options of Approximately $113 Million for Oral TPOXX and Approximately $25 Million for IV TPOXX under Current Contract reflects continuing global action to enhance smallpox preparedness
NEW YORK, July 27, 2023 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (NASDAQ: SIGA), a commercial-stage pharmaceutical company, today announced that the U.S. Department of Health and Human Services exercised procurement options for the delivery of approximately $113 million worth of oral TPOXX® treatment courses and approximately $25 million worth of IV TPOXX® treatment courses.

“Building on the orders SIGA received for TPOXX from 13 international customers and the U.S. Department of Defense in 2022, these most recent procurement orders further highlight that many global leaders in public heath recognize the importance of orthopoxvirus preparedness and the need to take action to keep people safe,” said Phil Gomez, CEO of SIGA. “We are pleased that we are able to consistently meet demand for oral TPOXX, which is driving substantial and increasingly diversified global revenue opportunities at SIGA.”

SIGA expects to fully deliver approximately $113 million of oral TPOXX under this order in 2023 and expects to start delivering IV TPOXX under this order in 2024. Prior to delivery of IV TPOXX under this order, SIGA will be focused on fulfilling delivery obligations under a prior IV TPOXX order.

This project has been supported in whole or in part with federal funds from the U.S. Department of Health and Human Services; Administration for Strategic Preparedness and Response; Biomedical Advanced Research and Development Authority (BARDA) and Strategic National Stockpile, under Contract No. 75A50118C00019.
👍️0
KeepOn KeepOn 2 년 전
This volitile stock is ready for a steady climb.
👍️0
buckysherm buckysherm 2 년 전
NIH doing gain of function research to make monkeypox 100 times more deadly. Hey, that’s good for business.
👍️0
buckysherm buckysherm 2 년 전

NIH trying to drum up more business for pharma.
👍️0
axelvento axelvento 2 년 전
STOMP is a NIAID-funded clinical trial led by the ACTG to evaluate the effectiveness of the antiviral tecovirimat, also know as TPOXX, for the treatment of human monkeypox infection.

stomptpoxx.org/main
👍️0
axelvento axelvento 2 년 전
The team hopes results may be available before Christmas

Oxford University launch new clinical trial to test a treatment for monkeypox

https://www.ox.ac.uk/news/2022-08-24-oxford-university-launch-new-clinical-trial-test-treatment-monkeypox

alert!
👍️0
axelvento axelvento 2 년 전
Monkeypox infection and resolution after treatment with tecovirimat in two patients with HIV disease

https://journals.sagepub.com/doi/10.1177/20499361221138349

$SIGA
👍️0
axelvento axelvento 2 년 전
In vitro and in vivo efficacy of Tecovirimat against a recently emerged 2022 Monkeypox virus isolate

approval coming soon$$$$$$$

https://pubmed.ncbi.nlm.nih.gov/36318038/
👍️0
axelvento axelvento 2 년 전
CHRISTINA HUTSON, CDC [00:20:10]
Because of these findings, from the start of the outbreak, we have been monitoring the F13L gene within sequenced isolates. At this time, CDC has analyzed sequence data for more than 4,000 specimens from across the United States, of which 11 were found to have genetic changes in the F13L gene during those sequence surveillance efforts.
When tested within the lab, using a cell culture based sensitivity assay, those 11 isolates were sensitive to tecovirimat, showing no evidence of resistance.
We’re currently working on a health advisory related, in part, to development of tecovirimat resistance virus during prolonged tecovirimat treatment. We wanted to let everyone know that this would be coming out soon, and there’ll be more information for providers about the potential for tecovirimat resistance.

-And we hope to have that HAN out by the middle of next week-

https://www.getrevue.co/profile/alexander_tin/issues/notes-for-11-14-2022-1459787
👍️0
buckysherm buckysherm 2 년 전
Is Monkeypox still about 95+% sexually transmitted ?
👍️0
axelvento axelvento 2 년 전
Tecovirimat is effective against human monkeypox virus in vitro at nanomolar concentrations

https://www.nature.com/articles/s41564-022-01269-8
👍️0
axelvento axelvento 2 년 전
ER is good: Approximately $61 Million of International Sales in the Third Quarter –

As of September 30, 2022, we had $109.7 million in cash and cash equivalents compared with $103.1 million at December 31, 2021.

As of September 30, 2022, we had outstanding purchase orders associated with manufacturing obligations in the aggregate amount of approximately $21.8 million.



https://investor.siga.com/news-releases/news-release-details/siga-reports-financial-results-three-and-nine-months-ended-0

Biden Admin Renews Public Health Emergency Over Monkeypox

https://www.zerohedge.com/medical/biden-admin-renews-public-health-emergency-over-monkeypox
👍️0
axelvento axelvento 2 년 전
WHO declares monkeypox still a global health emergency
WHO kept monkeypox on its highest alert level

https://www.foxnews.com/health/who-declares-monkeypox-still-global-health-emergency
👍️0
axelvento axelvento 2 년 전
CDC has altered their view and comments about the effectiveness of TPOXX. Their website, updated on Oct 18, now reads:

"While monkeypox symptoms can resolve on their own, treatment for orthopoxviruses is available and can provide relief and decrease disease severity for persons with monkeypox. The treatment is tecovirimat (TPOXX), available as a pill or intravenous (IV) infusion. At this time, TPOXX is available through state and territorial health departments and CDC."

https://www.cdc.gov/poxvirus/monkeypox/health-departments/intervention-services.html
👍️0
axelvento axelvento 2 년 전
IN CENTRAL AFRICA, A DEADLY MONKEYPOX VARIANT IS SURGING

https://www.nationalgeographic.co.uk/science-and-technology/2022/10/in-central-africa-a-deadly-monkeypox-variant-is-surging/amp



New York and Nevada report first monkeypox deaths

https://news.yahoo.com/u-monkeypox-deaths-rise-4-184822233.html
👍️0
axelvento axelvento 2 년 전
Mass General Brigham studying whether antiviral tecovirimat helps treat monkeypox

https://www.bostonherald.com/2022/10/19/mass-general-brigham-studying-whether-antiviral-tecovirimat-helps-treat-monkeypox/
👍️0
axelvento axelvento 2 년 전
a 2week old infant....."A 2-week course of enteral tecovirimat (at a dose of 50 mg twice a day) was commenced in combination with intravenous cidofovir. After 4 weeks in intensive care, including 14 days of invasive ventilation, the infant recovered and was discharged home."

https://www.nejm.org/doi/full/10.1056/NEJMc2210828
👍️0
ktcougar ktcougar 2 년 전
Almost back to where it started......
👍️0
axelvento axelvento 2 년 전
https://www.nih.gov/news-events/news-releases/monkeypox-treatment-trial-begins-democratic-republic-congo

SIGA winner
👍️0
axelvento axelvento 2 년 전
SIGA Provides Update on Progress in Clinical Trials
SIGA disclosed that the Company had received, as of mid September, approximately $76 million of international orders for oral TPOXX from twelve international customers.

https://investor.siga.com/news-releases/news-release-details/siga-provides-update-progress-clinical-trials-assess-use-tpoxx-r
👍️0
axelvento axelvento 2 년 전
Monkeypox: A dangerous variant circulating in the DRC could go global


https://www.newscientist.com/article/2341569-monkeypox-a-dangerous-variant-circulating-in-the-drc-could-go-global/


$SIGA
👍️0
axelvento axelvento 2 년 전
CEO: https://www.edisongroup.com/edison-tv/siga-technologies-executive-interview-3/

$SIGA
👍️0
axelvento axelvento 2 년 전
Q3 ended last week. At least $80m in sales compared to $9m reported Q2. Nov 4'ish should have the Q3 pr$$$$$$$$
👍️0
axelvento axelvento 2 년 전
The monkeypox virus is mutating. Are scientists worried


If health officials detect an uptick in the number of virus samples carrying these mutations, that could be a possible signal that they are helping the virus to spread.

The good news is that, although the monkeypox virus continues to evolve, no mutations have affected the part of its genome that encodes a protein targeted by tecovirimat, an antiviral drug being tested for use against monkeypox in humans.

https://www.nature.com/articles/d41586-022-03171-z
👍️0
Ecomike Ecomike 2 년 전
Awesome DD you are sharing here, many thanks.

I am close to buying more shares... Looking for the bottom to add..
👍️0
Ecomike Ecomike 2 년 전
To score grant R&D money for testing improved versions, just in case?

"and say a mutation may be one amino acid away from rendering this drug totally useless"
👍️0
axelvento axelvento 2 년 전
NEWS OUT: SIGA Technologies Announces New Contract Awarded by U.S. Department of Defense for the Procurement of up to $10.7 Million of Oral TPOXX®

https://investor.siga.com/news-releases/news-release-details/siga-technologies-announces-new-contract-awarded-us-department
👍️0
axelvento axelvento 2 년 전
SIGA expects to complete delivery of these most recent orders in 2022. To date this year, including the recent orders, SIGA has received approximately $76 million of international orders for oral TPOXX (tecovirimat) from twelve international customers. It is currently expected that at least $65 million of these orders will be delivered in 2022.
👍️0
axelvento axelvento 2 년 전
news: SIGA Announces Approximately $16 Million of International Procurement Orders Received in August and Early September for Oral TPOXX® (Tecovirimat)
September 26, 2022 at 10:07 AM EDT

https://investor.siga.com/news-releases/news-release-details/siga-announces-approximately-16-million-international
👍️0
axelvento axelvento 2 년 전
Today, the Commission has secured over 10,000 treatment courses of tecovirimat to treat Monkeypox.

https://ec.europa.eu/commission/presscorner/detail/en/ip_22_5482
👍️0
axelvento axelvento 2 년 전
approval in brazil: https://www.gov.br/anvisa/pt-br/assuntos/noticias-anvisa/2022/anvisa-aprova-liberacao-do-medicamento-para-monkeypox-para-uso-pelo-ministerio-da-saude
👍️0
axelvento axelvento 2 년 전
SIGA Technologies has now secured the rights to sell TPOXX to commercial customers and is working to make this life-saving medication more widely available


https://stock.vi.app/market-price/siga-technologies-to-sell-tpoxx-to-commercial-customers/


winners$$$$$$$$$$$
👍️0
axelvento axelvento 2 년 전
Vanderbilt researchers are developing an artificial intelligence algorithm that can precisely track and count monkeypox lesions. They are also spearheading the effort to develop lesion classification guidelines, which will be used when evaluating the potential use of tecovirimat, an antiviral that is FDA-approved against smallpox, as a therapy for monkeypox.

https://news.vanderbilt.edu/2022/09/15/vanderbilt-nih-and-the-institut-national-de-recherche-biomedicale-team-up-to-tackle-monkeypox%e2%80%af/
👍️0

최근 히스토리

Delayed Upgrade Clock